{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:37:31Z","timestamp":1791171451164,"version":"4.1.0"},"reference-count":24,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,1,19]],"date-time":"2009-01-19T00:00:00Z","timestamp":1232323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Given the key role of interleukin\u20105 (IL\u20105) in eosinophil function, we investigated the regulated expression of the membrane\u2010anchored (TM\u2010IL\u20105R\u03b1) isoform, or a secreted (SOL IL\u20105R\u03b1) isoform, on both protein and transcript level <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> A real\u2010time PCR, FACS and ELISA were established to determine IL\u20105R\u03b1 isoform expression in peripheral blood and nasal tissue from control subjects and nasal polyp (NP) patients with or without asthma. Human peripheral blood eosinophils were incubated with IL\u20105 and were analyzed for SOL\u2010IL\u20105R\u03b1 and TM\u2010IL\u20105R\u03b1 mRNA and protein levels in comparison with CD\u201069 expression.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> SOL\u2010IL\u20105R\u03b1 and TM\u2010IL\u20105R\u03b1 mRNA and protein expression was significantly increased in NP <jats:italic>vs<\/jats:italic> controls. In polyp tissue, SOL\u2010IL\u20105R\u03b1 expression correlated to disease severity and eosinophils counts, whereas TM\u2010IL\u20105R\u03b1 levels were inversely correlated to eosinophils counts and SOL\u2010IL\u20105R\u03b1 expression. FACS analysis revealed increased CD\u201069 and decreased TM\u2010IL\u20105R\u03b1 expression in NP tissue eosinophils <jats:italic>vs<\/jats:italic> blood eosinophils. Incubation of blood eosinophils with IL\u20105 caused up\u2010regulation of CD\u201069 and down\u2010regulation of TM\u2010IL\u20105R\u03b1 after 2 and 24\u2003h.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> The expression of SOL\u2010IL\u20105R\u03b1 and TM\u2010IL\u20105R\u03b1 differs according to the eosinophil activation state and localization in the body (blood <jats:italic>vs<\/jats:italic> tissue) and may therefore be involved in the fine\u2010tuning of the eosinophil homeostasis. Exposure of eosinophils to IL\u20105 reduces their responsiveness to IL\u20105 by regulated expression of the IL\u20105R\u03b1 isoforms. Since, TM\u2010IL\u20105R\u03b1 is down\u2010regulated and SOL\u2010IL\u20105R\u03b1 (antagonistic) is upregulated in NP tissue, our findings are important to understand the clinical trials with anti\u2010IL\u20105 in humans.<\/jats:p>","DOI":"10.1111\/j.1398-9995.2008.01885.x","type":"journal-article","created":{"date-parts":[[2009,1,19]],"date-time":"2009-01-19T07:50:01Z","timestamp":1232351401000},"page":"725-732","source":"Crossref","is-referenced-by-count":40,"title":["Differential expression of the interleukin 5 receptor \u03b1 isoforms in blood and tissue eosinophils of nasal polyp patients"],"prefix":"10.1111","volume":"64","author":[{"given":"P.","family":"Gevaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lundblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lundahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Holtappels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Van Cauwenberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tavernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bachert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1159\/000053724"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.12.3101.bloodjournal79123101"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.3.1538"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.158.8.3902"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03496-6"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.05.031"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200208-789OC"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2304001"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90040-6"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0706465"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.5.1600.005k22_1600_1607"},{"key":"e_1_2_8_13_2","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.4049\/jimmunol.160.9.4427","article-title":"Selective inhibition of IL\u20105 receptor alpha\u2010chain gene transcription by IL\u20105, IL\u20103, and granulocyte\u2010macrophage colony\u2010stimulating factor in human blood eosinophils","volume":"160","author":"Wang P","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.11.6459"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.11.6452"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.11.5359"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2003.00110.x"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.2500\/105065800781329573"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(91)90315-7"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990090107"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-3-17"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2002-3-7-research0034"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2004.01986.x"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.112374"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2003.02051.x"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.2008.01885.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.2008.01885.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T22:26:31Z","timestamp":1695939991000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.2008.01885.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1111\/j.1398-9995.2008.01885.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.2008.01885.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}